Stock MYCO.F MYDECINE INNOVATIONS GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Mydecine Innovations Group Inc.

Equities

MYCO.F

CA62849F2008

Market Closed - OTC Markets
Other stock markets
 02:13:19 2024-05-31 pm EDT 		5-day change 1st Jan Change
0.0061 USD -26.51% Intraday chart for Mydecine Innovations Group Inc. -43.52% -59.06%
May. 01 Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding CI
Feb. 23 Mydecine Innovations Closes Partial Debt Settlement MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mydecine Provides Bi-Weekly Status Report
AQ
Mydecine Provides Bl-Weekly Status Report
AQ
Mydecine Applies for Management Cease Trade Order
AQ
Mydecine Receives Management Cease Trade Order
AQ
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting
AQ
Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding
CI
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order
AQ
Mydecine Innovations Group Inc. Announces Share for Debt Settlement
AQ
Mydecine Innovations Closes Partial Debt Settlement
MT
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
GL
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
AQ
Mydecine Innovations Group Announces Director Resignation
GL
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director
CI
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound
MT
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
GL
Mydecine Announces Update Regarding the Special Access Program
GL
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
GL
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements
AQ
Mydecine Innovations Group Provided Q4 2023 Business Update
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MYCO.F Stock
  4. News Mydecine Innovations Group Inc.